|
LOC729082 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1564972030319E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.23910004058115E-09 |
| Normal-vs-Stage2 |
2.43779999999916E-05 |
| Normal-vs-Stage3 |
1.71884728672467E-12 |
| Normal-vs-Stage4 |
9.74039737755561E-11 |
| Stage1-vs-Stage2 |
9.984200E-01 |
| Stage1-vs-Stage3 |
1.087900E-02 |
| Stage1-vs-Stage4 |
2.592400E-02 |
| Stage2-vs-Stage3 |
8.668400E-02 |
| Stage2-vs-Stage4 |
8.548400E-02 |
| Stage3-vs-Stage4 |
7.683200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26410001857857E-11 |
| Normal-vs-AfricanAmerican |
2.283200E-03 |
| Normal-vs-Asian |
2.15849999984918E-07 |
| Caucasian-vs-AfricanAmerican |
1.708180E-01 |
| Caucasian-vs-Asian |
6.808400E-01 |
| AfricanAmerican-vs-Asian |
1.718620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51323398256409E-13 |
| Normal-vs-Female |
1.96700000731909E-09 |
| Male-vs-Female |
1.745890E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.33619999997947E-06 |
| Normal-vs-Age(41-60Yrs) |
1.53210777398272E-14 |
| Normal-vs-Age(61-80Yrs) |
2.67559999711509E-08 |
| Normal-vs-Age(81-100Yrs) |
7.203400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.195600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.143800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.868400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.756020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.465000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.371600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.107790E-01 |
| Classical-VS-Follicular |
9.758300E-02 |
| Classical-VS-Other |
3.238400E-01 |
| Classical-VS-Normal |
4.54970505714414E-11 |
| Tall-VS-Follicular |
2.840100E-02 |
| Tall-VS-Other |
8.603600E-01 |
| Tall-VS-Normal |
8.02529998011892E-09 |
| Follicular-VS-Other |
3.736100E-02 |
| Follicular-VS-Normal |
5.88369999999783E-05 |
| Other-VS-Normal |
2.613100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.48050033238678E-10 |
| Normal-vs-N1 |
4.57800020114973E-10 |
| N0-vs-N1 |
9.102200E-02 |
|
|
